Belite Bio (BLTE) Return on Assets (2023 - 2026)

Belite Bio's Return on Assets history runs 4 years deep, the most recent figure standing at 0.8% for Q1 2026.

• On a quarterly basis, Return on Assets rose 99.0% year-over-year to 0.8% in Q1 2026; TTM through Mar 2026 was 0.8%, a 99.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Assets climbed to 0.8% in Q1 2026 per BLTE's latest filing, from 1.19% in the prior quarter.
• Across five years, Return on Assets topped out at 0.8% in Q1 2026 and bottomed at 3.21% in Q2 2023.
• The 4-year median for Return on Assets is 2.19% (2025), against an average of 2.02%.
• Biggest YoY gain for Return on Assets was 162 bps in 2024; the steepest drop was 89 bps in 2024.
• Year by year, Return on Assets stood at 1.8% in 2023, then sank by 50 bps to 2.7% in 2024, then jumped by 56 bps to 1.19% in 2025, then jumped by 33 bps to 0.8% in 2026.
• Per Business Quant, the three latest BLTE Return on Assets figures stand at 0.8% (Q1 2026), 1.19% (Q4 2025), and 2.19% (Q3 2025).